Furthermore, suppression of the angiogenesis pathway alone is not sufficient to inhibit the growth of AFP-positive HCC because it only prolongs the median overall survival by approximately 1.2 months [9]. This evidence concerns the gene AFP and hepatocellular carcinoma.